825647-69-6 Usage
Description
3-METHYL-1-(PYRIDIN-2-YL)BUTAN-1-AMINE is an organic compound that serves as a key reactant in the synthesis of various pharmaceutical compounds. It is characterized by its unique molecular structure, which includes a methyl group, a pyridine ring, and a butylamine chain. 3-METHYL-1-(PYRIDIN-2-YL)BUTAN-1-AMINE plays a crucial role in the development of new therapeutic agents, particularly in the field of oncology.
Uses
Used in Pharmaceutical Industry:
3-METHYL-1-(PYRIDIN-2-YL)BUTAN-1-AMINE is used as a reactant in the preparation of (heterocyclyl)phenylindazolecarboxamides. These compounds are known as tyrosine threonine kinase inhibitors and have potential antitumor properties. They are being developed as targeted therapies for the treatment of various types of cancer, offering a more precise approach to cancer treatment compared to traditional chemotherapy.
In the development of tyrosine threonine kinase inhibitors, 3-METHYL-1-(PYRIDIN-2-YL)BUTAN-1-AMINE contributes to the formation of the heterocyclyl group, which is an essential component of these inhibitors. The presence of this group allows the inhibitors to selectively target and bind to specific tyrosine kinases, enzymes that play a critical role in cell growth and division. By inhibiting the activity of these enzymes, the proliferation of cancer cells can be effectively controlled, leading to a reduction in tumor size and growth.
Furthermore, the use of 3-METHYL-1-(PYRIDIN-2-YL)BUTAN-1-AMINE in the synthesis of these inhibitors highlights its importance in the field of medicinal chemistry. As researchers continue to explore the potential of tyrosine kinase inhibitors as antitumor agents, the demand for this compound as a reactant is likely to increase. This underscores the significance of 3-METHYL-1-(PYRIDIN-2-YL)BUTAN-1-AMINE in the ongoing efforts to develop novel and effective cancer treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 825647-69-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,5,6,4 and 7 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 825647-69:
(8*8)+(7*2)+(6*5)+(5*6)+(4*4)+(3*7)+(2*6)+(1*9)=196
196 % 10 = 6
So 825647-69-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H16N2/c1-8(2)7-9(11)10-5-3-4-6-12-10/h3-6,8-9H,7,11H2,1-2H3
825647-69-6Relevant articles and documents
KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME
-
Paragraph 0262, (2014/02/15)
The present teachings provide a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.
INDAZOLE COMPOUNDS AS KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME
-
Page/Page column 107, (2013/04/25)
The present teaching provide indazole compounds represented by Structural Formulae (I) or (I') or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof as protein kinase inhibitors, such as T
Chiral ligands containing heteroatoms; 9. General procedures for the synthesis of optically active 1-(2-pyridyl)alkylamines from α-amino acids
Falorni,Chelucci,Conti,Giacomelli
, p. 972 - 976 (2007/10/02)
General syntheses of 1-(2-pyridyl)alkylamines and N-methyl or N,N-dimethyl-1-(2-pyridyl)alkylamines from optically active α-amino acids are described. The presented procedures are based on catalyzed co-cyclotrimerization of the suitable nitriles with acet
